Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance.
Wang LM, Wang P, Chen XM, Yang H, Song SS, Song Z, Jia L, Chen HD, Bao XB, Guo N, Huan XJ, Xi Y, Shen YY, Yang XY, Su Y, Sun YM, Gao YL, Chen Y, Ding J, Lang JY, Miao ZH, Zhang A, He JX.
Wang LM, et al. Among authors: huan xj.
EMBO Mol Med. 2023 Mar 8;15(3):e16235. doi: 10.15252/emmm.202216235. Epub 2023 Jan 18.
EMBO Mol Med. 2023.
PMID: 36652375
Free PMC article.